Visualizing the randomized sham-controlled trial in orthopedic research: proposed steps to conducting a total knee arthroplasty randomized controlled trial.
Audrey A TranVinay PrasadPublished in: Journal of comparative effectiveness research (2023)
Performed more than 600,000 times annually in the USA alone, total knee arthroplasty is the one of the most common and costly elective operations in the world. A primary total knee arthroplasty is generally an elective procedure, for which total index hospitalization costs are estimated around $30,000 USD. Roughly four in five patients declare they are satisfied postoperatively, justifying the procedure's frequency and high costs. It is sobering to realize, however, that the evidence base in favor of this procedure remains circumstantial. We as a profession lack randomized trials showing a subjective improvement over placebo intervention. We argue for the necessity of sham-controlled surgical trials in this setting and provide a surgical atlas showing how a sham operation may be performed.
Keyphrases
- total knee arthroplasty
- double blind
- randomized controlled trial
- total hip
- placebo controlled
- clinical trial
- study protocol
- end stage renal disease
- phase iii
- minimally invasive
- open label
- patients undergoing
- newly diagnosed
- ejection fraction
- chronic kidney disease
- phase ii
- peritoneal dialysis
- prognostic factors
- single cell
- systematic review
- living cells
- depressive symptoms